Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kolb HJ . Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112: 4371–4383.

    Article  CAS  Google Scholar 

  2. Spierings E, Goulmy E . Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 2005; 115: 3397–3400.

    Article  CAS  Google Scholar 

  3. Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1 or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742–2747.

    Article  CAS  Google Scholar 

  4. Gallardo D, Aróstegui JI, Balas A, Torres A, Caballero D, Carreras E et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931–936.

    Article  CAS  Google Scholar 

  5. Lin MT, Gooley T, Hansen JA, Tseng LH, Martin EG, Singleton K et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood 2001; 98: 3172–3173.

    Article  CAS  Google Scholar 

  6. Pérez-García A, De la Cámara R, Torres A, González M, Jiménez A, Gallardo D . Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. Haematologica 2005; 90: 1723–1724.

    PubMed  Google Scholar 

  7. Gallardo D, Pérez-García A, de la Cámara R, Iriondo A, Jiménez-Velasco A, Torres A et al. Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source. Leukemia 2006; 20: 1461–1464.

    Article  CAS  Google Scholar 

  8. Oostvogels R, Minnema MC, van Elk M, Spaapen RM, te Raa GD, Giovannone B et al. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia 2013; 27: 642–649.

    Article  CAS  Google Scholar 

  9. Spierings E, Drabbels J, Hendriks M, Pool J, Spruyt-Gerritse M, Claas F et al. A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS One 2006; 1: e42.

    Article  Google Scholar 

  10. Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A et al. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 1244–1253.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work has been partially financed by grant FIS11/01690 from the Fondo de investigaciones sanitarias, Health Ministery of Spain, and by grant MTV3/120210 from Fundació Marató TV3. We are also grateful for the financial support given by the association ‘Llavaneres contra el càncer’.

Author contributions

AB-V and DG performed the statistical analysis and wrote the letter; RR-R, GO-G and AB-V performed the laboratory work; JBN, RC, SB, CV, CM-L, IB, AU-I, MG and AJ-V recruited the samples and the clinical information.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to A Jiménez-Velasco.

Ethics declarations

Competing interests

The authors declare no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bosch-Vizcaya, A., Rodriguez-Romanos, R., Nieto, J. et al. Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT. Bone Marrow Transplant 50, 298–300 (2015). https://doi.org/10.1038/bmt.2014.234

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/bmt.2014.234

Search

Quick links